Skip to main content
. 2019 Jul 24;35(6):341–349. doi: 10.1089/jop.2019.0020

Table 1.

Mean ± Standard Deviation of the Maximal Concentration (Cmax) and Time to Reach Cmax (Tmax) for Prednisone and Prednisolone in Control and Conjunctivitis Eyes

  Prednisone Prednisolone
  Cmax (ng/mL) Tmax (min) Cmax (ng/mL) Tmax (min)
Dose 1 (0.5 mg/kg)
 Control 23.2 ± 13.4 77.5 ± 89.7 19.2 ± 19.5 115.0 ± 99.3
 Conjunctivitis 55.1 ± 68.1 87.5 ± 85.1 22.4 ± 26.7 130.0 ± 86.3
Dose 2 (1.0 mg/kg)
 Control 47.7 ± 26.4 140.0 ± 187.3 29.2 ± 24.9 215.0 ± 257.0
 Conjunctivitis 48.1 ± 25.5 87.5 ± 85.1 37.1 ± 32.1 145.0 ± 166.9
Dose 3 (2.0 mg/kg)
 Control 91.7 ± 74.7 127.5 ± 97.6 75.3 ± 64.3 420.0 ± 211.3#
 Conjunctivitis 137.2 ± 115.5 65.0 ± 22.6 62.7 ± 31.3 320.0 ± 196.0
Dose 4 (4.0 mg/kg)
 Control 116 ± 67.2# 127.5 ± 93.8 123.6 ± 47.8#,† 160.0 ± 92.3
 Conjunctivitis 204.3 ± 173.5 120.0 ± 180.7 120.0 ± 38.1#,†,‡ 160.0 ± 92.3

Within the same drug dose, comparisons between control and conjunctivitis eyes did not reveal any statistical differences (P > 0.05). Within the same ocular group (control or conjunctivitis), differences among doses are depicted with symbols to demonstrate statistically greater values compared to dose 1 (#), dose 2 (†), and dose 3 (‡).